Revenue and EBITDA Growth
SelectQuote reported a 19% increase in revenue, reaching $481 million, and a 30% increase in adjusted EBITDA, totaling $88 million compared to the previous year.
Medicare Advantage Performance
The Senior division delivered robust results with Medicare Advantage policy volume growing by 6%, impressive agent productivity, and a 39% adjusted EBITDA margin, up from 32% the previous year.
SelectRx Membership Expansion
SelectRx membership grew by 54% year-over-year, with revenues reaching $183 million, representing a 64% increase. The segment concluded with an annual run rate exceeding $700 million.
Capital Structure Improvement
SelectQuote secured a $350 million preferred equity offering led by Bain Capital and others, to improve capital structure. This move is expected to decrease ongoing capital costs by over 150 basis points and reduce annual cash interest obligations by approximately $30 million.
Guidance Increase
The company raised its fiscal 2025 guidance ranges for revenue, adjusted EBITDA, and net income, expecting revenue between $1.5 billion and $1.575 billion, and adjusted EBITDA between $115 million and $140 million.